Colorectal Cancer

Targeted clinician intervention might improve follow-up colonoscopy rates: Exact Sciences funded study
Reported follow-up colonoscopy rates within community settings are low, ranging from 18% to 75% within 12 months of a positive stool-based test result, failing to achieve the full benefits of widespread at-home screening.
January 18, 2023
Colon Disease Social
At J.P. Morgan healthcare conference, Exact Sciences CEO describes pivotal meeting for Cologuard development
Kevin Conroy described a meeting in 2009 that changed everything for him as a business executive. Exact Sciences, without a proof of concept, was looking for a CEO to restart the company and develop a noninvasive colon cancer screening test.
January 10, 2023
Colon Intestine Social
Personalis to collaborate with UCSF on colorectal cancer treatment study
The study will use the Next Personal assay to evaluate circulating tumor DNA (ctDNA)-based signatures associated with treatment response and adverse events in a cohort of patients with late-stage CRC who are receiving a combination therapy.
November 30, 2022
Colorectal Cancer Social
Universal Diagnostics study assesses methylation biomarkers' role in early colorectal cancer
The company will present the findings at the AACR Special Conference on Precisions, Prevention, Early Detection, and Interception of Cancer being held in Austin, TX, November 17-19.
November 17, 2022
Colon Cancer Social
Mainz Biomed initiates U.S. extension of colorectal cancer study to evaluate mRNA biomarkers
Mainz Biomed announced an extension of its ColoFuture European study, which aims to evaluate the use of mRNA biomarkers for the early detection of colorectal cancer.
November 15, 2022
Colorectal Cancer Social
Nucleai to present data on multiplex immunofluorescence analysis for colorectal cancer research
Nucleai will present data this week demonstrating the capability of multiplex immunofluorescence analysis to correlate spatial features with patient outcomes in colorectal cancer.
November 7, 2022
Colorectal Cancer Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
Exact Sciences shares rise with 15% growth in Q3 revenues
Screening segment revenue, including sales for the Cologuard colon cancer molecular test, was $360.8 million, an increase of 29% year-over-year.
November 4, 2022
Colon Intestine Social
Exact Sciences to present data on positive impact of Cologuard
The firm said it will present data supporting the positive impact of its Cologuard molecular colorectal cancer screening tool during the American College of Gastroenterology Annual Meeting.
October 24, 2022
Colon Intestine Social
Exact Sciences awards $525K in grants to improve CRC screening
Exact's Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) program provided the grant funding. Awardees will use the funds to implement evidence-based and informed intervention strategies proven to increase colorectal cancer screening rates, the firm said.
September 21, 2022
2022 01 05 21 34 8683 Check Mark
Natera presents colorectal, breast cancer data at ESMO 2022
One abstract, related to the Bellini trial, examined the potential clinical utility of circulating tumor DNA (ctDNA) in assessing the response to neoadjuvant immunotherapy in patients with early-stage (I-II) triple-negative breast cancer (TNBC).
September 12, 2022
2019 07 27 00 04 3609 Breast Cancer Cell 400
Indica Labs, iCAIRD partner on AI for colon cancer
Using anonymized hematoxylin and eosin (H&E) slides from the National Health Service Greater Glasgow and Clyde (NHSGGC) digital pathology archive, Indica and iCAIRD will collaboratively train, validate, and test the algorithm, which will be designed to detect cancer within lymph nodes from colorectal surgery cases.
August 29, 2022
2020 01 08 00 29 4037 Colon Cancer 400
Geneoscopy wraps up enrollment for colorectal cancer trial
The pivotal trial will assess the ability of the company's at-home, noninvasive test for detecting colorectal cancer and advanced adenomas in average-risk individuals.
August 22, 2022
2019 11 04 19 56 0311 Colorectal Cancer 400
Page 1 of 4
Next Page